Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases
ACS Omega · 31.01.2023 · 8 (4) · 3667-3683
DOI: 10.1021/acsomega.2c06098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 17.01.2023. Verfasst von Afshin Babazadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New…. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The brain is vulnerable to different types of stresses, particularly oxidative stress as a result of oxygen requirements/utilization in the body. Large amounts of unsaturated fatty acids present in the brain increase this vulnerability. Neurodegenerative diseases (NDDs) are brain disorders that are characterized by the gradual loss of specific neurons and are attributed to broad evidence of cell-level oxidative stress. The accurate characterization of neurological disorders relies on several parameters along with genetics and environmental risk factors, making therapies less efficient to fight NDDs. On the way to tackle oxidative damage and discover efficient and safe therapies, bioactives are at the edge of NDD science. Naturally occurring bioactive compounds such as polyphenols, carotenoids, essential fatty acids, phytosterols, essential oils, etc. are particularly of interest owing to their potent antioxidant and anti-inflammatory activities, and they offer lots of brain-health-promoting features. This Review focuses on probing the neuroefficacy and bioefficacy of bioactives and their role in supporting relatively low antioxidative and low regenerative capacities of the brain, neurogenesis, neuroprotection, and ameliorating/treating NDDs.
Autor:innen und Institutionen
- Center for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, China.
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225009, China.
- Technical University of Munich Campus Straubing for Biotechnology and Sustainability, Essigberg 3, 94315 Straubing, Germany.
- German Institute of Food Technologies (DIL e.V.), Prof.-von-Klitzing-Straße 7, 49610 D Quakenbrück, Germany.
- Faculty of Medicine, University of California, Riverside, California 92679, United States.
ORCID-Profile: Seid Mahdi Jafari
Zitieren
APA
Babazadeh, A., Vahed, F. M., Liu, Q., Siddiqui, S. A., Kharazmi, M. S., & Jafari, S. M. (2023). Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases. ACS Omega, 8(4), 3667-3683. https://doi.org/10.1021/acsomega.2c06098
Vancouver
Babazadeh A, Vahed FM, Liu Q, Siddiqui SA, Kharazmi MS, Jafari SM. Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases. ACS Omega. 2023;8(4):3667-3683. doi:10.1021/acsomega.2c06098
BibTeX
@article{Babazadeh2023,
author = {Babazadeh, Afshin and Vahed, Fereshteh Mohammadi and Liu, Qi and Siddiqui, Shahida Anusha and Kharazmi, Mohammad Saeed and Jafari, Seid Mahdi},
title = {Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {4},
pages = {3667--3683},
doi = {10.1021/acsomega.2c06098}
}
EUVIMED